TipRanks
Go Ultimate55% OFF

Kailera Therapeutics, Inc. (KLRA) Income Statement

Kailera Therapeutics, Inc. Income Statement

Last quarter (Q2 2026), Kailera Therapeutics, Inc.'s total revenue was $0.00. In Q2, Kailera Therapeutics, Inc.'s net income was $-111.31M. See Kailera Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25
$ 0.00
$ 0.00
$ 158.34M
Depreciation and Amortization$ 310.00K
$ -158.03M
$ -158.34M
$ 9.38M
$ -148.96M
$ -148.96M
Per Share Metrics
Basic EPS$ -1.26
Diluted EPS$ -1.26
Weighted Average Shares Outstanding117.95M
Weighted Average Shares Outstanding (Diluted)117.95M

Currency in USD

Kailera Therapeutics, Inc. Earnings and Revenue History

-180M-120M-60M00 %0.4 %0.8 %1.2 %EarningsProfit Margin2025RevenueEarningsProfit Margin